Cargando…
Macrophage Activation Syndrome
Hemophagocytic lymphohistiocytosis (HLH), or termed macrophage activation syndrome (MAS) when associated with rheumatic disorders, is a frequently fatal complication of infections, rheumatic disorders, and hematopoietic malignancies. Clinically, HLH/MAS is a life-threatening condition that is usuall...
Autores principales: | Eloseily, Esraa M., Cron, Randy Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123081/ http://dx.doi.org/10.1007/978-3-319-79026-8_14 |
Ejemplares similares
-
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
por: Eloseily, Esraa M. A., et al.
Publicado: (2019) -
The Immunology of Macrophage Activation Syndrome
por: Crayne, Courtney B., et al.
Publicado: (2019) -
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
por: Mehta, Puja, et al.
Publicado: (2020) -
Pediatric-onset limited ANCA-associated vasculitis arising during pre-existing chronic recurrent multifocal osteomyelitis
por: Eloseily, Esraa, et al.
Publicado: (2023) -
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
por: Crayne, Courtney B., et al.
Publicado: (2018)